Due to the reversible nature of targeting metabolic enzymes with small molecule inhibitors, targeting the metabolic enzymes induced by IL-6 can be used to fine tune inflammation associated with autoimmune disease or viral infection without causing deleterious effects on protective immunity. The gene discussed is IL6; the disease is autoimmune disease.